filanesib
Showing 1 - 1 of 1
Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,
Completed
- Plasma Cell Leukemia
- +2 more
- Carfilzomib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 12, 2019